Amy Peterson
2022 - CytomX Therapeutics
In 2022, Amy Peterson earned a total compensation of $1.8M as Former President and Chief Operating Officer at CytomX Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Option Awards | $489,960 |
|---|---|
| Salary | $445,752 |
| Stock Awards | $165,200 |
| Other | $747,123 |
| Total | $1,848,035 |
Peterson received $747.1K in other compensation, accounting for 40% of the total pay in 2022.
Peterson also received $490K in option awards, $445.8K in salary and $165.2K in stock awards.
Rankings
In 2022, Amy Peterson's compensation ranked 1,886th out of 5,760 executives tracked by ExecPay. In other words, Peterson earned more than 67.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,886 out of 5,760 | 67th |
Division Manufacturing | 997 out of 3,136 | 68th |
Major group Chemicals And Allied Products | 415 out of 1,422 | 71st |
Industry group Drugs | 380 out of 1,323 | 71st |
Industry Pharmaceutical Preparations | 273 out of 969 | 72nd |
Source: SEC filing on April 27, 2023.
Peterson's colleagues
We found four more compensation records of executives who worked with Amy Peterson at CytomX Therapeutics in 2022.
News
CytomX Therapeutics CEO Sean McCarthy's 2022 pay falls 31% to $3M
April 27, 2023
CytomX Therapeutics CEO Sean McCarthy's 2021 pay jumps 52% to $4.3M
April 27, 2022
BeiGene, Ltd. CEO John Oyler's 2019 pay falls 55% to $13M
April 28, 2020
BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
April 29, 2019